5 Tips To Guide Your EHR Through Meaningful Use Stage 2

Follow

Looking for tips to navigate MU stage 2 requirements?  View one tip on drug-drug and drug-allergy interaction checks below and visit http://www.dosespot.com/meaningful-use-tips to download all 5 certification tips!

Meaningful Use Stage 2: Tip #2 –

§ 170.314(a)(2) Drug-drug, drug-allergy interaction checks

Objective: In addition to providing drug-drug and drug-allergy interaction checks, this criteria requires EHRs to adjust the level of interactions based on user roles (ie: administrator).

Tip: Provide an easy-to-use user interface so a user can quickly adjust the interactions. DoseSpot allows the user to turn on and off the drug-drug and drug-allergy interactions as well adjust the severity level display between minor, moderate and major interactions.

Click here for more blog posts at ePrescribing.org on Meaningful Use.

CMS Updates Meaningful Use Stages 2 and 3 Timeline

Follow

The Centers for Medicare & Medicaid Services (CMS) recently announced that Meaningful Use Stage 2 will be extended through 2016 and Stage 3 will be delayed until 2017.  In a joint blog post on CMS.gov, Robert Tagalicod (CMS) and Jacob Reider (Office of the National Coordinator for Health Information Technology, ONC) explain “the goal of this change is two-fold: first, to allow CMS and ONC to focus efforts on the successful implementation of the enhanced patient engagement, interoperability and health information exchange requirements in Stage 2; and second, to utilize data from Stage 2 participation to inform policy decisions for Stage 3.”

The post highlights a number of benefits to the new timeframe including:

• More analysis of feedback from stakeholders on Stage 2 progress and outcomes;

• More available data on Stage 2 adoption and measure calculations – especially on new patient engagement measures and health information exchange objectives;

• More consideration of potential Stage 3 requirements;

• Additional time for preparation for enhanced Stage 3 requirements;

• Ample time for developers to create and distribute certified EHR technology before Stage 3 begins, and incorporate lessons learned about usability and customization.

To read the announcement in full, visit www.cms.gov/eHealth/ListServ_Stage3Implementation.html.